HK1248545A1 - 通過管理藻類生物質調節免疫和炎症反應的方法 - Google Patents

通過管理藻類生物質調節免疫和炎症反應的方法

Info

Publication number
HK1248545A1
HK1248545A1 HK18108238.5A HK18108238A HK1248545A1 HK 1248545 A1 HK1248545 A1 HK 1248545A1 HK 18108238 A HK18108238 A HK 18108238A HK 1248545 A1 HK1248545 A1 HK 1248545A1
Authority
HK
Hong Kong
Prior art keywords
methods
inflammatory responses
algal biomass
modulating immune
via administration
Prior art date
Application number
HK18108238.5A
Other languages
English (en)
Inventor
Andrew A Dahl
Amy E Steffek
Original Assignee
Zivo Bioscience Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zivo Bioscience Inc filed Critical Zivo Bioscience Inc
Publication of HK1248545A1 publication Critical patent/HK1248545A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/02—Antioxidant
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK18108238.5A 2015-02-16 2018-06-26 通過管理藻類生物質調節免疫和炎症反應的方法 HK1248545A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562116766P 2015-02-16 2015-02-16
PCT/US2016/018105 WO2016133922A1 (en) 2015-02-16 2016-02-16 Methods of modulating immune and inflammatory responses via administration of an algal biomass

Publications (1)

Publication Number Publication Date
HK1248545A1 true HK1248545A1 (zh) 2018-10-19

Family

ID=56689161

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18108238.5A HK1248545A1 (zh) 2015-02-16 2018-06-26 通過管理藻類生物質調節免疫和炎症反應的方法

Country Status (8)

Country Link
US (1) US11065287B2 (zh)
EP (1) EP3258948B1 (zh)
BR (1) BR112017017599B1 (zh)
CA (1) CA3011687A1 (zh)
ES (1) ES2972377T3 (zh)
HK (1) HK1248545A1 (zh)
PL (1) PL3258948T3 (zh)
WO (1) WO2016133922A1 (zh)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10765732B2 (en) 2013-06-13 2020-09-08 Zivo Bioscience, Inc. Compounds and methods for affecting cytokines
US10842179B2 (en) 2010-02-22 2020-11-24 Zivo Bioscience, Inc. Agents and mechanisms for treating hypercholesterolemia
US11065287B2 (en) 2015-02-16 2021-07-20 Zivo Bioscience, Inc. Methods of modulating immune and inflammatory responses via administration of an algal biomass
US11806375B2 (en) 2016-02-16 2023-11-07 Zivo Bioscience, Inc. Nutritional support for animals via administration of an algal derived supplement

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10166270B2 (en) 2004-04-23 2019-01-01 Zivo Bioscience, Inc. Composition and method for affecting cytokines and NF-κB
WO2018165205A1 (en) * 2017-03-07 2018-09-13 Zivo Bioscience, Inc. Dietary supplements, food ingredients and foods comprising high-protein algal biomass
PL3897188T3 (pl) * 2018-12-21 2024-04-29 Zivo Bioscience, Inc. Algowy składnik pasz do kontroli skutków kokcydiozy i nekrotycznego zapalenia jelit u drobiu
JP2023553202A (ja) 2020-12-08 2023-12-20 ルミナント バイオテク コーポレーション リミテッド 動物に物質を送達するための装置および方法の改善
AU2022209715A1 (en) * 2021-01-15 2023-07-20 Zivo Bioscience, Inc. Algoriphagus sp, bosea sp, brevundimonas sp, desulfovibrio sp, microbacterium sp, sphingomonas sp, and variovorax sp for use in disease prevention and treatment

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012504A (en) 1972-05-12 1977-03-15 Velvet Chemical Co. Iodine mineral oil solution for preventing bovine mastitis
JPS55142249A (en) 1979-04-24 1980-11-06 Shionogi & Co Ltd Reduction type ascorbic acid detecting composition and test piece
US4475196A (en) 1981-03-06 1984-10-02 Zor Clair G Instrument for locating faults in aircraft passenger reading light and attendant call control system
US4447233A (en) 1981-04-10 1984-05-08 Parker-Hannifin Corporation Medication infusion pump
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4471055A (en) 1982-03-26 1984-09-11 Minnesota Mining And Manufacturing Company Process and kit for determining concentrations of aldehydes
US4447224A (en) 1982-09-20 1984-05-08 Infusaid Corporation Variable flow implantable infusion apparatus
US4487603A (en) 1982-11-26 1984-12-11 Cordis Corporation Implantable microinfusion pump system
US4486194A (en) 1983-06-08 1984-12-04 James Ferrara Therapeutic device for administering medicaments through the skin
JPS6219528A (ja) 1985-07-16 1987-01-28 Kurorera Kogyo Kk 制癌剤
US4959217A (en) 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
US4925678A (en) 1987-04-01 1990-05-15 Ranney David F Endothelial envelopment drug carriers
US5080646A (en) 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
US5167616A (en) 1989-12-14 1992-12-01 Alza Corporation Iontophoretic delivery method
US6631842B1 (en) 2000-06-07 2003-10-14 Metrologic Instruments, Inc. Method of and system for producing images of objects using planar laser illumination beams and image detection arrays
US5225182A (en) 1991-10-31 1993-07-06 Sharma Yash P Vectored drug delivery system using a cephaloplastin linking agent and a methed of using the system
AU6821294A (en) * 1993-04-30 1994-11-21 Rodner R. Winget Anti-inflammatory compositions containing eicosapentaenoic acid bearing monogalactosyldiacylglycerol and methods relating thereto
US5726063A (en) 1993-05-06 1998-03-10 Oxis Isle Of Man, Limited Method of colorimetric analysis of malonic dialdehyde and 4-hydroxy-2-enaldehydes as indexes of lipid peroxidation, kits for carrying out said method, substituted indoles for use in said method and their preparation
JPH0940523A (ja) 1995-07-28 1997-02-10 Ichimaru Pharcos Co Ltd クロレラ水抽出物含有線維芽細胞増殖促進物質
US6461607B1 (en) 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
US6673908B1 (en) 1999-02-22 2004-01-06 Nuvelo, Inc. Tumor necrosis factor receptor 2
ATE270558T1 (de) 1999-08-26 2004-07-15 Ganeden Biotech Inc Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
WO2001022834A2 (en) 1999-09-27 2001-04-05 Algal Ltd. Vegetarian foodstuff
US6235495B1 (en) 1999-11-12 2001-05-22 Oxis International, Inc. Methods for the quantitation of oxidized glutathione
CA2354832C (en) 2000-08-10 2002-05-14 Ocean Nutrition Canada Ltd. Chlorella preparations exhibiting immunomodulating properties
WO2002015917A1 (en) 2000-08-18 2002-02-28 Atlas World Usa, Inc. Use of agaricus blazei murill to prevent or treat skin and other disorders
EP1230927A1 (en) 2001-02-12 2002-08-14 Allegrini S.p.a. Phyto-derivative disinfectant solution for veterinary use in the endo-mammary anti-mastitis treatment of milk-producing animals
US7578132B2 (en) 2001-03-03 2009-08-25 Rolls-Royce Plc Gas turbine engine exhaust nozzle
US6374874B1 (en) 2001-06-22 2002-04-23 Robert W. Payne Sand bag loading system
TWI318881B (zh) 2001-09-27 2010-01-01
US7125846B2 (en) 2001-11-09 2006-10-24 Novo Nordisk Healthcare A/G Pharmaceutical composition comprising factor VII polypeptides and factor V polypeptides
AU2003287622A1 (en) 2002-11-06 2004-06-03 Fraunhofer Usa Expression of foreign sequences in plants using trans-activation system
US7025965B1 (en) * 2003-02-12 2006-04-11 Pharma Chemie, Inc. Method of use and dosage composition of bluegreen algae extract for inflammation in animals
DE10324548A1 (de) 2003-05-28 2004-12-16 Nutrinova Nutrition Specialties & Food Ingredients Gmbh Diätisches Lebensmittel bei einer gewichtskontrollierenden bzw. gewichtsreduzierenden Ernährung
US20050260695A1 (en) 2003-09-23 2005-11-24 Genprime, Inc. Methods, compositions, devices, and kits for detecting mastitis
CA2564466A1 (en) 2004-04-23 2005-12-01 Health Enhancement Products, Inc. Method of preparation and use of fibrinolytic enzymes in the treatment of disease
US10166270B2 (en) 2004-04-23 2019-01-01 Zivo Bioscience, Inc. Composition and method for affecting cytokines and NF-κB
US7807622B2 (en) 2004-04-23 2010-10-05 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
US20130251698A1 (en) 2010-10-04 2013-09-26 Health Enhancement Products, Inc. Composition and method for affecting cytokines and nf-kb
WO2006113925A2 (en) 2005-04-20 2006-10-26 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
CA2485449A1 (en) * 2004-10-08 2006-04-08 Biotec Pharmacon Asa Method for preventing mucositis during cancer therapy
US7854467B2 (en) 2004-11-05 2010-12-21 General Motors Corporation Airflow control devices based on active materials
US7216831B2 (en) 2004-11-12 2007-05-15 The Boeing Company Shape changing structure
US7546727B2 (en) 2004-11-12 2009-06-16 The Boeing Company Reduced noise jet engine
CA2625818A1 (en) 2005-04-20 2006-10-26 Health Enhancement Products, Inc. Composition and use of phyto-percolate for treatment of disease
JP2009518312A (ja) 2005-12-02 2009-05-07 ヘルス エンハンスメント プロダクツ インク 疾患を治療するための植物浸出物の組成物および使用
WO2007140287A2 (en) 2006-05-25 2007-12-06 Dr. Reddy's Laboratories, Inc. Use of biomarkers of inflammation as indicators of drug efficacy
CA2654608A1 (en) 2006-06-07 2007-12-13 Reddy Us Therapeutics, Inc. Compositions and methods to enhance reverse cholesterol transport
US7958733B2 (en) 2006-06-20 2011-06-14 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Jet engine exhaust nozzle flow effector
GB0614114D0 (en) 2006-07-15 2006-08-23 Rolls Royce Plc An actuator
WO2008039911A1 (en) 2006-09-28 2008-04-03 Purrfect Gourmet, Llc Algal biomeal-based palatability enhancer and method of use and manufacture therefor
WO2010017346A2 (en) 2008-08-08 2010-02-11 The Dial Corporation Consumer products comprising algae derived ingredients
US8434293B2 (en) 2009-08-06 2013-05-07 The Boeing Company High stiffness shape memory alloy actuated aerostructure
CA2780144A1 (en) 2009-11-16 2011-05-19 Health Enhancement Products, Inc. Use of an extract derived from atcc #pta-5863 as an anti-inflammatory and anti-viral agent
US8518132B2 (en) 2009-12-11 2013-08-27 Albert C. Rettenmaier Methods of algae harvesting utilizing a filtering substance and uses therefor
MX2012009678A (es) 2010-02-22 2013-06-03 Health Enhancement Products Inc Agentes y mecanismos para tratar la hipercolesterolemia.
US8685707B2 (en) 2010-06-14 2014-04-01 Heinz Ploechinger Construction material made of algae, method for cultivating algae, and algae cultivation plant
CN102225127B (zh) * 2011-06-21 2012-08-15 北京九草堂药物研究院有限公司 一种治疗奶牛乳腺炎的中药组合物
JP2014006051A (ja) * 2012-06-21 2014-01-16 Univ Of Tsukuba 放射性同位元素の除去剤および除去方法
WO2014201372A1 (en) * 2013-06-13 2014-12-18 Health Enhancement Products, Inc. Compounds and methods for affecting cytokines
US11065287B2 (en) 2015-02-16 2021-07-20 Zivo Bioscience, Inc. Methods of modulating immune and inflammatory responses via administration of an algal biomass
US11806375B2 (en) 2016-02-16 2023-11-07 Zivo Bioscience, Inc. Nutritional support for animals via administration of an algal derived supplement
WO2018165205A1 (en) 2017-03-07 2018-09-13 Zivo Bioscience, Inc. Dietary supplements, food ingredients and foods comprising high-protein algal biomass

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10842179B2 (en) 2010-02-22 2020-11-24 Zivo Bioscience, Inc. Agents and mechanisms for treating hypercholesterolemia
US10765732B2 (en) 2013-06-13 2020-09-08 Zivo Bioscience, Inc. Compounds and methods for affecting cytokines
US11065287B2 (en) 2015-02-16 2021-07-20 Zivo Bioscience, Inc. Methods of modulating immune and inflammatory responses via administration of an algal biomass
US11806375B2 (en) 2016-02-16 2023-11-07 Zivo Bioscience, Inc. Nutritional support for animals via administration of an algal derived supplement

Also Published As

Publication number Publication date
BR112017017599A2 (pt) 2018-05-08
EP3258948C0 (en) 2023-12-06
ES2972377T3 (es) 2024-06-12
WO2016133922A1 (en) 2016-08-25
PL3258948T3 (pl) 2024-04-22
US20180021392A1 (en) 2018-01-25
US11065287B2 (en) 2021-07-20
EP3258948A4 (en) 2018-09-12
BR112017017599B1 (pt) 2021-11-16
EP3258948A1 (en) 2017-12-27
EP3258948B1 (en) 2023-12-06
CA3011687A1 (en) 2016-08-25

Similar Documents

Publication Publication Date Title
HK1248545A1 (zh) 通過管理藻類生物質調節免疫和炎症反應的方法
HK1258041A1 (zh) 免疫細胞組合物和使用方法
EP3096782A4 (en) Compositions and methods for modulating and redirecting immune responses
EP3142496A4 (en) Direct-fed microbials and methods of their use
EP3210262A4 (en) Connectors with movable magnetic components and method of connecting devices
EP3110946A4 (en) Methods and compositions for inducing differentiation of human brown adipocyte progenitors
IL266883A (en) Device and methods for a photobioreactor
IL250818A0 (en) Methods and preparations for increasing immune responses
EP3209395A4 (en) Exercise device and method of using same
EP3008995A4 (en) CULTIVATION ORGANISM GROWING METHOD, AND CULTIVATION PLANT
EP3229837A4 (en) Methods for upregulating immune responses using combinations of anti-rgmb and anti-pd-1 agents
EP3107567A4 (en) Methods of modulating an immune response
EP3099443A4 (en) Induction devices and methods of using them
IL264179B (en) Preparations that include micro-algae and methods for their preparation and uses
IL259743B (en) Bioreactor apparatus and methods
GB201417362D0 (en) Devices and methods for selection of microbial strains
GB201709838D0 (en) Method of modulating immune cells
EP3204014A4 (en) Methods of modulating immune system responses
EP3171705A4 (en) Protein rich food ingredient from biomass and methods of preparation
EP3151858A4 (en) Antibody guided vaccines and methods of use for generation of rapid mature immune responses
EP3092269A4 (en) Thermoplastic gel compositions and their methods of making
SI3220946T1 (sl) Sestave in metode za lajšanje in preprečevanje vnetja črevesja zaradi prisotnosti antigenov peptidnih živil v črevesu
EP3107890A4 (en) Branched-chain esters and methods of making and using the same
EP3227453A4 (en) Extracts of whole stillage and other biomass and methods thereof
EP3215521A4 (en) Cd8 and t cell receptor variants and methods of using same in modulating immune cell responses